O'Connell J E, Gray C S
South Tyneside District Hospital, South Shields, Tyne, England.
Drugs Aging. 1996 Jun;8(6):408-15. doi: 10.2165/00002512-199608060-00002.
Cerebrovascular disease is a common cause of morbidity and mortality, especially in the elderly. Treatment of hypertension is effective in the primary prevention of stroke. Hypertension is seen in 80% of acute stroke patients but, by the tenth day after admission to hospital, only one-third are still hypertensive. The clinical significance of post-stroke hypertension is uncertain and its management is a contentious issue. In this article we review current evidence regarding the risks and benefits of the treatment of post-stroke hypertension. The pathophysiology of post-stroke hypertension is described in relation to autoregulation of cerebral blood flow after cerebral infarction or haemorrhage. In the absence of clinical trial data, recommendations for early treatment of post-stroke hypertension are based on a review of expert opinion that immediate, controlled lowering of blood pressure after acute stroke is required only in defined situations such as hypertensive encephalopathy or aortic dissection. There are no reliable data regarding the comparative effects of different hypotensive agents after acute stroke; short-acting vasodilator drugs are recommended if treatment is essential. The benefits of hypotensive therapy in secondary prevention of recurrent stroke are uncertain but the results of large clinical trials in progress should provide helpful guidelines for clinical practice.
脑血管疾病是发病和死亡的常见原因,在老年人中尤为如此。高血压治疗对中风的一级预防有效。80%的急性中风患者存在高血压,但入院后第十天时,只有三分之一的患者仍处于高血压状态。中风后高血压的临床意义尚不确定,其治疗是一个有争议的问题。在本文中,我们综述了有关中风后高血压治疗风险和益处的现有证据。阐述了中风后高血压的病理生理学与脑梗死后或脑出血后脑血流自动调节的关系。在缺乏临床试验数据的情况下,中风后高血压早期治疗的建议基于对专家意见的综述,即仅在高血压脑病或主动脉夹层等特定情况下,才需要在急性中风后立即、控制性地降低血压。关于急性中风后不同降压药物的比较效果,尚无可靠数据;如果必须进行治疗,推荐使用短效血管扩张剂。降压治疗在复发性中风二级预防中的益处尚不确定,但正在进行的大型临床试验结果应为临床实践提供有用的指导方针。